Morpheus
SENIOR MEMBER
- Joined
- Mar 5, 2017
- Messages
- 3,060
- Reaction score
- -1
- Country
- Location
World's first inactivated Covid-19 vaccine produces antibodies
(Karachi) The phase one and two clinical trials of the world's first inactivated coronavirus vaccine have produced antibodies in participants, Chinese experts revealed on Sunday.
The vaccine is developed by Wuhan Institute of Biological Products under the China National Biotec Group (CNBG) affiliated to the China National Pharmaceutical Group (Sinopharm).
All 1,120 volunteers in phase Ⅰ/Ⅱ clinical trials have successfully made #antibodies against the #COVID19 after accepting two doses of the #COVID19 vaccine made by an institute under Sinopharm CNBG in Beijing. The vaccine has proven to be effective and safe. pic.twitter.com/k9VXBTbeCh
— Global Times (@globaltimesnews) June 28, 2020
According to researchers, the results of the clinical trial showed that the vaccination is safe and has no serious reaction. They stated that after adopting different procedures and doses of vaccination, all 1,120 participants in the vaccine group produced high titers of antibodies.
"People who received two doses of the vaccine at an interval of 28 days, saw their neutralizing antibody positive conversion rate reach 100 percent," experts maintained.
On April 12, the vaccine obtained the world's first clinical trial approval, and phase one and two clinical trials were then launched in Wuzhi county of Henan province. The vaccine will prove to be a breakthrough to contain spread of Covid-19.
https://www.brecorder.com/news/4000...9-vaccine-produces-antibodies-chinese-experts
-----------------
- Researchers say results of the clinical trial showed that the vaccination is safe and has no serious reaction
(Karachi) The phase one and two clinical trials of the world's first inactivated coronavirus vaccine have produced antibodies in participants, Chinese experts revealed on Sunday.
The vaccine is developed by Wuhan Institute of Biological Products under the China National Biotec Group (CNBG) affiliated to the China National Pharmaceutical Group (Sinopharm).
All 1,120 volunteers in phase Ⅰ/Ⅱ clinical trials have successfully made #antibodies against the #COVID19 after accepting two doses of the #COVID19 vaccine made by an institute under Sinopharm CNBG in Beijing. The vaccine has proven to be effective and safe. pic.twitter.com/k9VXBTbeCh
— Global Times (@globaltimesnews) June 28, 2020
According to researchers, the results of the clinical trial showed that the vaccination is safe and has no serious reaction. They stated that after adopting different procedures and doses of vaccination, all 1,120 participants in the vaccine group produced high titers of antibodies.
"People who received two doses of the vaccine at an interval of 28 days, saw their neutralizing antibody positive conversion rate reach 100 percent," experts maintained.
On April 12, the vaccine obtained the world's first clinical trial approval, and phase one and two clinical trials were then launched in Wuzhi county of Henan province. The vaccine will prove to be a breakthrough to contain spread of Covid-19.
https://www.brecorder.com/news/4000...9-vaccine-produces-antibodies-chinese-experts
-----------------
